These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 33096402)
1. Validation of the COVID-19 Fears Questionnaires for Chronic Medical Conditions: A Scleroderma Patient-centered Intervention Network COVID-19 Cohort study. Wu Y; Kwakkenbos L; Henry RS; Tao L; Harb S; Bourgeault A; Carrier ME; Levis B; Sun Y; Bhandari PM; Carboni-Jiménez A; Gagarine M; He C; Krishnan A; Negeri ZF; Neupane D; Mouthon L; Bartlett SJ; Benedetti A; Thombs BD; ; J Psychosom Res; 2020 Dec; 139():110271. PubMed ID: 33096402 [TBL] [Abstract][Full Text] [Related]
2. Factors associated with fears due to COVID-19: A Scleroderma Patient-centered Intervention Network (SPIN) COVID-19 cohort study. Wu Y; Kwakkenbos L; Henry RS; Carrier ME; Gagarine M; Harb S; Bourgeault A; Tao L; Carboni-Jiménez A; Negeri Z; Patten S; Bartlett SJ; Mouthon L; Varga J; Benedetti A; Thombs BD; ; J Psychosom Res; 2021 Jan; 140():110314. PubMed ID: 33271402 [TBL] [Abstract][Full Text] [Related]
3. Validity, Reliability, and Differential Item Functioning of English and French Versions of the 10-Item Connor-Davidson Resilience Scale in Systemic Sclerosis: A Scleroderma Patient-Centered Intervention Network Cohort Study. Neyer MA; Henry RS; Carrier ME; Kwakkenbos L; Wojeck RK; Gietzen A; Gottesman K; Guillot G; Lawrie-Jones A; Mayes MD; Mouthon L; Nielson WR; Richard M; Worron-Sauvé M; Harel D; Malcarne VL; Bartlett SJ; Thombs BD; Arthritis Care Res (Hoboken); 2023 Nov; 75(11):2369-2378. PubMed ID: 37128826 [TBL] [Abstract][Full Text] [Related]
4. Validation of the Self-Efficacy for Managing Chronic Disease Scale: A Scleroderma Patient-Centered Intervention Network Cohort Study. Riehm KE; Kwakkenbos L; Carrier ME; Bartlett SJ; Malcarne VL; Mouthon L; Nielson WR; Poiraudeau S; Nielsen K; Baron M; Frech T; Hudson M; Pope J; Sauve M; Suarez-Almazor ME; Wigley FM; Thombs BD; Arthritis Care Res (Hoboken); 2016 Aug; 68(8):1195-200. PubMed ID: 26619042 [TBL] [Abstract][Full Text] [Related]
5. Psychometric properties of The COVID-19 Fears Questionnaire for Chronic Medical Conditions in patients with pre-existing medical conditions. Buneviciene I; Bunevicius R; Bagdonas S; Bunevicius A Health Soc Care Community; 2022 Sep; 30(5):e2866-e2873. PubMed ID: 35088481 [TBL] [Abstract][Full Text] [Related]
6. Validity of the Fear of Progression Questionnaire-Short Form in patients with systemic sclerosis. Kwakkenbos L; van den Hoogen FH; Custers J; Prins J; Vonk MC; van Lankveld WG; Becker ES; van den Ende CH Arthritis Care Res (Hoboken); 2012 Jun; 64(6):930-4. PubMed ID: 22262505 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of Measurement Properties and Differential Item Functioning in the English and French Versions of the University of California, Los Angeles, Loneliness Scale-6: A Scleroderma Patient-Centered Intervention Network (SPIN) Study. S Rapoport C; Choi AK; Kwakkenbos L; Carrier ME; Henry RS; Mouthon L; Roesch SC; Thombs BD; Malcarne VL; ; Arthritis Care Res (Hoboken); 2023 Oct; 75(10):2158-2165. PubMed ID: 36938696 [TBL] [Abstract][Full Text] [Related]
8. Validation of the Social Appearance Anxiety Scale in Patients With Systemic Sclerosis: A Scleroderma Patient-Centered Intervention Network Cohort Study. Mills SD; Kwakkenbos L; Carrier ME; Gholizadeh S; Fox RS; Jewett LR; Gottesman K; Roesch SC; Thombs BD; Malcarne VL; Arthritis Care Res (Hoboken); 2018 Oct; 70(10):1557-1562. PubMed ID: 29342510 [TBL] [Abstract][Full Text] [Related]
9. Development and validation of the brief-satisfaction with appearance scale for systemic sclerosis. Jewett LR; Hudson M; Haythornthwaite JA; Heinberg L; Wigley FM; Baron M; Thombs BD; Arthritis Care Res (Hoboken); 2010 Dec; 62(12):1779-86. PubMed ID: 20665750 [TBL] [Abstract][Full Text] [Related]
10. Reliability and Validity of Three Versions of the Brief Fear of Negative Evaluation Scale in Patients With Systemic Sclerosis: A Scleroderma Patient-Centered Intervention Network Cohort Study. Fox RS; Kwakkenbos L; Carrier ME; Mills SD; Gholizadeh S; Jewett LR; Roesch SC; Merz EL; Assassi S; Furst DE; Gottesman K; Mayes MD; Thombs BD; Malcarne VL; Arthritis Care Res (Hoboken); 2018 Nov; 70(11):1646-1652. PubMed ID: 29409146 [TBL] [Abstract][Full Text] [Related]
11. Changes in mental health symptoms from pre-COVID-19 to COVID-19 among participants with systemic sclerosis from four countries: A Scleroderma Patient-centered Intervention Network (SPIN) Cohort study. Thombs BD; Kwakkenbos L; Henry RS; Carrier ME; Patten S; Harb S; Bourgeault A; Tao L; Bartlett SJ; Mouthon L; Varga J; Benedetti A; ; J Psychosom Res; 2020 Dec; 139():110262. PubMed ID: 33070043 [TBL] [Abstract][Full Text] [Related]
12. Factor structure and convergent validity of the Derriford Appearance Scale-24 using standard scoring versus treating 'not applicable' responses as missing data: a Scleroderma Patient-centered Intervention Network (SPIN) cohort study. Merz EL; Kwakkenbos L; Carrier ME; Gholizadeh S; Mills SD; Fox RS; Jewett LR; Williamson H; Harcourt D; Assassi S; Furst DE; Gottesman K; Mayes MD; Moss TP; Thombs BD; Malcarne VL; BMJ Open; 2018 Mar; 8(3):e018641. PubMed ID: 29511009 [TBL] [Abstract][Full Text] [Related]
13. Measurement equivalence of the English and French versions of the self-efficacy to manage chronic disease scale: a Scleroderma Patient-Centered Intervention Network (SPIN) study. Choi AK; Rapoport CS; Kwakkenbos L; Carrier ME; Gottesman K; Roesch SC; Harel D; Thombs BD; Malcarne VL; Qual Life Res; 2024 Mar; 33(3):843-851. PubMed ID: 38191792 [TBL] [Abstract][Full Text] [Related]
14. Validation of the Body Concealment Scale for Scleroderma (BCSS): Replication in the Scleroderma Patient-centered Intervention Network (SPIN) Cohort. Jewett LR; Kwakkenbos L; Carrier ME; Malcarne VL; Harcourt D; Rumsey N; Mayes MD; Assassi S; Körner A; Fox RS; Gholizadeh S; Mills SD; Fortune C; Portales A; Thombs BD; Body Image; 2017 Mar; 20():99-106. PubMed ID: 28068643 [TBL] [Abstract][Full Text] [Related]
15. Designing and psychometric evaluation of disease-related fear scale (D-RFS) in adults with epilepsy: A sequential exploratory mixed methods design. Shamsalinia A; Moradi M; Farahani MA; Masoudi R; Ghadimi R; Rad RE; Ghaletaki GZ; Ghaffari F Epilepsy Behav; 2020 Sep; 110():107169. PubMed ID: 32504981 [TBL] [Abstract][Full Text] [Related]
16. Development and Validation of the Body Concealment Scale for Scleroderma. Jewett LR; Malcarne VL; Kwakkenbos L; Harcourt D; Rumsey N; Körner A; Steele RJ; Hudson M; Baron M; Haythornthwaite JA; Heinberg L; Wigley FM; Thombs BD; Arthritis Care Res (Hoboken); 2016 Aug; 68(8):1158-65. PubMed ID: 26663624 [TBL] [Abstract][Full Text] [Related]
17. Factor structure of 12 items in the Chinese Health Questionnaire among the elderly population in mainland China. Zhang CC; Hou LH; Zheng X; Lu J; Zou JY; Qian Y; Yang TZ Public Health; 2020 Oct; 187():143-149. PubMed ID: 32979605 [TBL] [Abstract][Full Text] [Related]
18. Development and validation of the Oxford Pandemic Attitude Scale-COVID-19 (OPAS-C): an internet-based cross-sectional study in the UK and USA. Kantor BN; Kantor J BMJ Open; 2021 Jul; 11(7):e043758. PubMed ID: 34261678 [TBL] [Abstract][Full Text] [Related]
19. Validation of Responsiveness of Physicians Scale (ROP-Scale) for hospitalised COVID-19 patients in Bangladesh. Joarder T; Islam MA; Islam MS; Mostari S; Hasan MT BMC Health Serv Res; 2022 Aug; 22(1):1040. PubMed ID: 35971120 [TBL] [Abstract][Full Text] [Related]
20. The Chinese version of the Perceived Stress Questionnaire: development and validation amongst medical students and workers. Meng R; Li J; Wang Z; Zhang D; Liu B; Luo Y; Hu Y; Yu C Health Qual Life Outcomes; 2020 Mar; 18(1):70. PubMed ID: 32169070 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]